FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
1. FDA approved MRNA's Spikevax for children at increased COVID-19 risk. 2. Updated Spikevax expected by 2025-2026 for eligible U.S. populations. 3. Moderna asserts patent rights against Pfizer and BioNTech's vaccine. 4. FDA limits COVID vaccine approvals to high-risk groups only. 5. MRNA stock rose 3.60% following the FDA approval news.